Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4

Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4

The establishment and maintenance of anti-tumor immune responses are the objectives of cancer immunotherapy. Despite recent promising advances, the effectiveness of these approaches has been limited by the multiple immunosuppressive mechanisms developed by tumors (checkpoint). The aim of the present...

Full description

Bibliographic Details
Main Authors: Nathalie Rouas-Freiss, Joel LeMaoult, Jérôme Verine, Diana Tronik-Le Roux, Stéphane Culine, Christophe Hennequin, François Desgrandchamps, Edgardo D. Carosella
Format: Article
Language:English
Published: Taylor & Francis Group 2017-09-01
Series:OncoImmunology
Subjects:
hla-g/ilt2/ilt4
immune checkpoint
immunotherapy
pd1/pdl1
renal-cell carcinoma
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1342023

Internet

http://dx.doi.org/10.1080/2162402X.2017.1342023

Similar Items